STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Ülke: Avustralya

Dil: İngilizce

Kaynak: Department of Health (Therapeutic Goods Administration)

Aktif bileşen:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Mevcut itibaren:

Sanofi-Aventis Australia Pty Ltd

INN (International Adı):

prochlorperazine mesilate

Farmasötik formu:

Injection

Kompozisyon:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Uygulama yolu:

Intramuscular

Paketteki üniteler:

10 x 1 mL

Reçete türü:

(S1) This Schedule is intentionally blank

Terapötik endikasyonlar:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Ürün özeti:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Yetkilendirme durumu:

Licence status A

Yetkilendirme tarihi:

2007-07-16